Send us Fan Mail

What do the latest findings from the 2025 San Antonio Breast Cancer Symposium mean for people living with metastatic breast cancer? 

In this episode, Dr. Bora Lim of MD Anderson Cancer Center joins us to break down the most impactful research and clinical trial updates from SABCS 2025. Together we will explore advances in hormone receptor positive, HER2-positive disease and triple negative disease and discuss how these updates may influence treatment decisions right now. We also wrap up with an audience Q&A, including questions about GLP-1 medications.

Listen in for expert insight, practical takeaways, and clarity on the evolving MBC treatment landscape.